BillionToOne, Inc. SEC filings BLLN
BillionToOne, Inc. has 178 filings in SEC EDGAR's recent list, going back to Jun 20, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 29, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Jun 10, 2026 |
| 10-K | Annual report | Mar 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Dec 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Dec 9, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 10, 2025 | Nov 7, 2025 |
| 424B4 | Prospectus | Nov 6, 2025 | — |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| CERT | Filing | Nov 5, 2025 | — |
| 8-A12B | Filing | Nov 3, 2025 | — |
| S-1/A | Amended registration statement | Oct 17, 2025 | — |
| S-1 | Registration statement | Oct 7, 2025 | — |
| DRSLTR | Filing | Sep 17, 2025 | — |
| DRS/A | Filing | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2025 | — |
| DRSLTR | Filing | Aug 11, 2025 | — |
| DRS/A | Filing | Aug 11, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2025 | — |
| DRS | Filing | Jun 20, 2025 | — |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- BLLN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2070849
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.